Blocking protein may be key to prevent obesity related diseases
Obesity is associated with the widespread epidemics of diabetes and heart disease, but a lesser-known fact is that the weight can also lead to autoimmune disease.
|Last Updated: Apr 05, 2013, 01:19 PM IST|Source: Bureau
Washington: Obesity is associated with the widespread epidemics of diabetes and heart disease, but a lesser-known fact is that the weight can also lead to autoimmune disease.
Now, researchers have shed light on how that damaging immune response happens and how it might be stopped.
The key, they showed, might be to block an important element known as AIM (for apoptosis inhibitor of macrophage) in the bloodstream and, ultimately, the production of antibodies that attack the self.
The discovery is especially notable because the team of researchers, from the University of Tokyo and led by Toru Miyazaki, previously discovered AIM, linking it to the inflammation that comes with obesity.
They also showed that its suppression could help prevent obesity-associated diabetes and atherosclerosis. Their new work extends those benefits of AIM suppression to include autoimmune disease.
"Our report for the first time explains how obesity causes an initial autoimmune response, namely production of multiple antibodies against self-antigens, and also defines a key molecule in this autoimmune process," Miyazaki said.
The researchers found that a natural immunoglobulin called IgM rises in the blood of mice fed on a high-fat diet. The rise in IgM results as fatty acids stimulate particular immune cells.
Furthermore, IgM binds to AIM, and this complex is retained in the blood rather than excreted in urine. The researchers propose that the prolonged presence of IgM-AIM in the blood may contribute to the production of auto-antibodies.
Correspondingly, they find that obese mice lacking AIM are protected from that harmful autoimmune response.
"Suppression of AIM appears to intercept two different obesity-associated pathological immune responses, namely, chronic inflammation based on innate immunity and autoantibody production based on humoral immunity," the researchers wrote.
"Thus, AIM inhibition potentially could be used as a therapy to prevent not only insulin resistance and metabolic disorders but also autoimmunity under obese conditions," they added.
Miyazaki`s team says that human studies are needed to pursue the development of a new AIM-targeted obesity therapy.
The research was published in Cell Reports, a Cell Press publication.
ANI
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookies Setting
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device and the processing of information obtained via those cookies (including about your preferences, device and online activity) by us and our commercial partners to enhance site navigation, personalise ads, analyze site usage, and assist in our marketing efforts. More information can be found in our Cookies and Privacy Policy. You can amend your cookie settings to reject non-essential cookies by clicking Cookie Settings below.
Manage Consent Preferences
Strictly Necessary Cookies
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work or you may not be able to login.
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They are also used to limit the number of times you see an advert as well as help measure the effectiveness of an advertising campaign. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we may not know when you have visited our site, and may not be able to monitor its performance.